Kinex Pharmaceuticals, Inc. (Kinex)

Oncology Corporate Profile

HQ Location

701 Ellicott Street
Buffalo, NY 14203

Company Description

Founded in 2004, Kinex is led by a strong, experienced Management Team and Board of Directors with a track record of achieving value-creating milestones and cumulative experience of over 150 years in both the pharmaceutical and biotechnology industries. This includes the filing of 11 NDAs and more than 20 INDs with the Food and Drug Administration and the development of 10 marketed products, including several blockbusters. Kinex has utilized the proprietary platform technologies Mimetica™, Opal™, and Orascovery™ to discover new compounds and to build a pipeline of drug candidates with unique mechanisms that address unmet medical needs with large market potential.


This company does not have any commercial products
  • Brand
  • Generic
  • Investigational
Brand / Product Class Area of Study Phase Partnership
KX02dual src/pre-tubulin inhibitorGliomaII
KX01tyrosine kinase inhibitorAcute Myelogenous Leukemia (AML)I


Recent News Headlines

There are no news items to display